Evolent Health, Inc. Quarterly Goodwill in USD from Q4 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Evolent Health, Inc. quarterly Goodwill history and growth rate from Q4 2014 to Q4 2024.
  • Evolent Health, Inc. Goodwill for the quarter ending December 31, 2024 was $1.14B, a 1.86% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.14B +$20.8M +1.86% Dec 31, 2024 10-K 2025-02-21
Q3 2024 $1.14B +$19.8M +1.77% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.12B -$1.02M -0.09% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.12B -$1.41M -0.13% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.12B +$394M +54.5% Dec 31, 2023 10-K 2025-02-21
Q3 2023 $1.12B +$395M +54.6% Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.12B +$691M +162% Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.12B +$692M +162% Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $723M +$296M +69.5% Dec 31, 2022 10-K 2025-02-21
Q3 2022 $723M +$374M +107% Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $426M +$77.2M +22.1% Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $426M +$77.3M +22.1% Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $426M +$77.3M +22.1% Dec 31, 2021 10-K 2025-02-21
Q3 2021 $349M -$7K 0% Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $349M +$19K +0.01% Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $349M -$221M -38.7% Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $349M -$217M -38.4% Dec 31, 2020 10-K 2023-02-24
Q3 2020 $349M -$423M -54.8% Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $349M -$423M -54.8% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $570M -$201M -26% Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $566M -$202M -26.3% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $772M +$137M +21.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $772M +$137M +21.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $770M +$135M +21.3% Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $768M +$140M +22.3% Dec 31, 2018 10-K 2021-02-26
Q3 2018 $635M +$6.75M +1.07% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $635M +$6.63M +1.05% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $635M +$8.04M +1.28% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $628M +$1.62M +0.26% Dec 31, 2017 10-K 2020-03-02
Q3 2017 $628M +$169M +36.7% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $629M +$169M +36.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $627M +$635K +0.1% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $627M +$17.7M +2.9% Dec 31, 2016 10-K 2019-02-28
Q3 2016 $460M -$149M -24.5% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $460M -$149M -24.5% Jun 30, 2016 10-Q 2016-11-10
Q1 2016 $627M Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $609M +$609M Dec 31, 2015 10-K 2018-03-01
Q3 2015 $609M Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $609M Jun 30, 2015 10-Q 2016-11-10
Q4 2014 $0 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.